Role of estrogen and estrogen-related growth factor in the mechanism of hormone dependency of endometrial carcinoma cells

Oncology

Volumn 55, Issue SUPPL. 1, 1998, Pages 35-43

  Hata, Hiroki ^a,b   Hamano, Mieko ^a   Watanabe, Jun ^a   Kuramoto, Hiroyuki ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KITASATO UNIVERSITY   (Japan)

Author keywords

Autocrine mechanism; C erbB 2 oncogene; Endometrial carcinoma; Estrogen; Hormone dependent tumor; Ishikawa cells; Transforming growth factor

Indexed keywords

CYTOKINE ANTIBODY; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; GROWTH FACTOR; ONCOPROTEIN; PROGESTERONE RECEPTOR; RECEPTOR ANTIBODY; TRANSFORMING GROWTH FACTOR ALPHA;

CANCER CELL CULTURE; CANCER GRADING; CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOMETRIUM CARCINOMA; HORMONE DEPENDENCE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; ONCOGENE C ERB; PRIORITY JOURNAL;

ADENOCARCINOMA; BLOTTING, WESTERN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOMETRIAL NEOPLASMS; EPIDERMAL GROWTH FACTOR; ESTROGENS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASMS, HORMONE-DEPENDENT; RECEPTOR, ERBB-2; TIME FACTORS; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR CELLS, CULTURED;

EID: 0032407925     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000055257     Document Type: Conference Paper

References (34)

1. Mosses HL, Branum EL, Proper JA, Robinson RA: Transforming growth factor production by chemically transformed cells. Cancer Res 1981; 41:2842-2848.
2. Roberts AB, Lamb LC, Newton DL, Sporn MB, De Larco JE, Todaro GJ: Transforming growth factors: Isolation of polypeptides from virally and chemically transformed cells by acid/ ethanol extraction. Proc Natl Acad Sci USA 1980;77:3494-3498.
3. Derynck R: Transforming growth factor-α. Cell 1988;54:593-595.
4. 1 cells. Endocrinology 1987;120:537-543.
5. Stoscheck CM, King LE Jr: Role of epidermal growth factor in carcinogenesis. Cancer Res 1986;46:1030-1037.
6. Reynolds FH, Todaro GJ: Human transforming growth factors induce tyrosine phosphorylation of EGF receptors. Nature (Lond) 1981;292:259-262.
7. Salomon DS, Kim N, Saeki T, Ciardiello F: Transforming growth factor-α: An oncodevelopmental growth factor. Cancer Cells 1990;2: 389-397.
8. Di Marco E, Pierce JH, Fleming TP, Kraus MH, Molloy CJ, Aaronson SA, Di Fiore PP: Autocrine interaction between TGF-α and the EGF receptor: Quantitative requirements for induction of the malignant phenotype. Oncogene 1989;4:831-838.
9. Sporn MB, Todaro GJ: Autocrine secretion and malignant transformation of cells. N Engl J Med 1980;303:878-880.
10. Lippman ME, Bolan G, Huff K: The effects of estrogen and antiestrogens on hormone-responsive human breast cancer in long-term culture. Cancer Res 1976;36:4595-4601.
11. Bates SE, Dickson RB, McManaway ME, Lippman LE: Characterization of estrogen responsive transforming activity in human breast cancer cell lines. Cancer Res 1986;46:1707-1713.
12. Davidson NE, Lippman LE: The role of estrogens in growth regulation of breast cancer. Crit Rev Oncog 1989;1:89-111.
13. Bates SE, Davidson NE, Valverius EM, Freter CE, Dickson RB, Tam JP, Kudlow JE, Lippman ME, Salomon DS: Expression of transforming growth factor-α and its messenger ribonucleic acid in human breast cancer: Its regulation by estrogen and its possible functional significance. Mol Endocrinol 1988;2:543-555.
14. Salomon DS, Kidwell WR, Kin N, Ciardiello F, Bates SE, Valverius EM, Lippman ME, Dickson RB, Stampfer MR: Modulation by estrogen and growth factors of transforming growth factor-α and epidermal growth factor receptor expression in normal and malignant human mammary epithelial cells. Recent Results Cancer Res 1989;113:57-69.
15. Saeki T, Cristiano A, Lynch MJ, Brattain M, Kim N, Normanno N, Kenney N, Ciardiello F, Salomon DS: Regulation by estrogen through the 5′-flanking region of the transforming growth factor-α gene. Mol Endocrinol 1991;5: 1955-1963.
16. Benraad TJ, Friberg LG, Koenders AJM, Kullander S: Do estrogen and progesterone receptors in metastasizing endometrial cancers predict the response to gestagen therapy? Acta Obstet Gynecol Scand 1980;59:155-159.
17. Ehrlich CE, Young PCM, Stehman FB, Sutton GP, Alford WM: Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium. Am J Obstet Gynecol 1988; 158:786-807.
18. Creasman WT, Soper JT, McCarty KS Jr, McCarty KS Sr, Hinshaw W, Clarke-Pearson DL: Influence of cytoplasmic steroid receptor content on prognosis of early stage endometrial carcinoma. Am J Obstet Gynecol 1985;151:922-932.
19. Liao BS, Twiggs LB, Leung BS, Yu WCY, Potish RA, Prem KA: Cytoplasmic estrogen and progesterone receptors as prognostic parameters in primary endometrial carcinoma. Obstet Gynecol 1986;67:463-467.
20. Nishida M, Kasahara K, Kaneko M, Iwasaki H: Establishment of a new human endometrial adenocarcinoma cell line, Ishikawa cells, containing estrogen and progesterone receptors. Acta Obstet Gynaecol Jpn 1985;37:1103-1111.
21. Holinka CF, Hata H, Gravanis A, Kuramoto H, Gurpide E: Effects of estradiol on proliferation of endometrial adenocarcinoma cells (Ishikawa line). J Steroid Biochem 1986;25:781-786.
22. Holinka CF, Hata H, Kuramoto H, Gurpide E: Effects of steroid hormones and antisteroids on alkaline phosphatase activity in human endometrial adenocarcinoma cells (Ishikawa line). Cancer Res 1986;46:271-274.
23. Hata H, Kuramoto H: Immunocytochemical determination of estrogen and progesterone receptors in human endometrial adenocarcinoma cells (Ishikawa cells). J Steroid Biochem Mol Biol 1992;42:201-210.
24. Anzai Y, Gong Y, Holinka CF, Murphy LJ, Murphy LC, Kuramoto H, Gurpide E: Effects of transforming growth factors and regulation of their mRNA levels in two human endometrial adenocarcinoma cell lines. J Steroid Biochem Mol Biol 1992;42:449-455.
25. Gong Y, Anzai Y, Murphy LC, Ballejo G, Holinka CF, Gurpide E, Murphy LJ: Transforming growth factor gene expression in human endometrial adenocarcinoma cells: Regulation by progestins. Cancer Res 1991;51:5476-5481.
26. Kuramoto H, Hamano M, Nishda M, Taguchi A, Jobo T, Suzuki M, Osanai K: Establishment of a new human endometrial carcinoma cell line derived from ascites. Acta Obstet Gynaecol Jpn 1976;28:1405-1406.
27. Yamamoto T, Ikawa S, Akiyama T, Semba K, Nomura N, Miyajima N, Saito T, Toyoshima K: Similarity of protein encoded by the human c-erbB-2 gene to epidermal growth factor receptor. Nature 1986;319:230-234.
28. Coussens L, Yang-Feng TL, Liao YU, Chen L, Gray A, McGrath J: Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science 1985;230:1132-1139.
29. Hata H, Hamano M, Tsujii A, Togasaki Y, Kuramoto H, Nishida M, Anzai Y, Gurpide E: In study for hormones and growth factors dependent cell proliferation of endometrial adenocarcinoma cells. Hum Cell 1993;6:182-187.
30. Wang DP, Konishi I, Koshiyama M, Mandai M, Nanbu Y, Ishikawa Y, Mori T, Fujii S: Expression of c-erbB-2 protein and epidermal growth factor receptor in endometrial carcinomas: Correlation with clinicopathologic and sex steroid hormone receptor status. Cancer 1993; 72:2628-2637.
31. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE: Studies of the HER-2/neu protooncogene in human breast and ovarian cancer. Science 1989;244:707-712.
32. Berchuck A, Rodriguez GC, Kamel A, Dodge RK, Soper JT, Clarke-Pearson DL: Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer. Cancer Res 1990;50:4087-4091.
33. Heatly M, Maxwell P, Whiteside CH, Toner PG: C-erbB-2 oncogene product expression depends on tumor type and is related to oestrogen receptor and lymph node status in human breast carcinoma. Pathol Res Pract 1993;189:261-266.
34. Bortoli MD, Maggiora P, Capello D, Antoniotti S, Saviozzi S, Sapei ML, Dati C: Hormonal control of growth factor receptor expression. Ann NY Acad Sci 1996;784:336-348.